Cargando…

Characterization of the role of Samsn1 loss in multiple myeloma development

The protein SAMSN1 was recently identified as a putative tumor suppressor in multiple myeloma, with re‐expression of Samsn1 in the 5TGM1/KaLwRij murine model of myeloma leading to a near complete abrogation of intramedullary tumor growth. Here, we sought to clarify the mechanism underlying this find...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friend, Natasha L., Hewett, Duncan R., Panagopoulos, Vasilios, Noll, Jacqueline E., Vandyke, Kate, Mrozik, Krzysztof M., Fitter, Stephen, Zannettino, Andrew C.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475304/ https://www.ncbi.nlm.nih.gov/pubmed/32923989 http://dx.doi.org/10.1096/fba.2020-00027

Ejemplares similares

SAMSN1 Is a Tumor Suppressor Gene in Multiple Myeloma()()
por: Noll, Jacqueline E., et al.
Publicado: (2014)

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice
por: Friend, Natasha, et al.
Publicado: (2020)

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo
por: Zeissig, Mara N., et al.
Publicado: (2020)

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
por: Noll, Jacqueline E., et al.
Publicado: (2015)

DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment
por: Hewett, Duncan R., et al.
Publicado: (2017)

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo
por: Clark, Kimberley C., et al.
Publicado: (2020)

Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo
por: Opperman, Khatora S., et al.
Publicado: (2019)

LCRF‐0006, a small molecule mimetic of the N‐cadherin antagonist peptide ADH‐1, synergistically increases multiple myeloma response to bortezomib
por: Mrozik, Krzysztof M., et al.
Publicado: (2020)

Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma
por: Bradey, Alanah L., et al.
Publicado: (2022)

Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma
por: Zeissig, Mara N., et al.
Publicado: (2020)

The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation
por: Vandyke, K, et al.
Publicado: (2011)

N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer
por: Mrozik, Krzysztof Marek, et al.
Publicado: (2018)

Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2017)

Deletion of Rptor in Preosteoblasts Reveals a Role for the Mammalian Target of Rapamycin Complex 1 (mTORC1) Complex in Dietary‐Induced Changes to Bone Mass and Glucose Homeostasis in Female Mice
por: Tangseefa, Pawanrat, et al.
Publicado: (2021)

SAMSN1 Is Highly Expressed and Associated with a Poor Survival in Glioblastoma Multiforme
por: Yan, Yong, et al.
Publicado: (2013)

Macrophage SAMSN1 protects against sepsis-induced acute lung injury in mice
por: Jiang, Wanli, et al.
Publicado: (2022)

Suppression of SAMSN1 contributes to neuroprotection in neonatal rats suffering from hypoxic–ischemic encephalopathy injury
por: Wang, Yi‐Bo, et al.
Publicado: (2022)

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
por: Dutta, Ankit K., et al.
Publicado: (2018)

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
por: Ebert, Lisa M., et al.
Publicado: (2021)

Using genomics to better define high-risk MGUS/SMM patients
por: Dutta, Ankit K., et al.
Publicado: (2018)

Lama2 And Samsn1 Mediate the Effects of Brn4 on Hippocampal Neural Stem Cell Proliferation and Differentiation
por: Zhang, Lei, et al.
Publicado: (2023)

Plant-derived soybean peroxidase stimulates osteoblast collagen biosynthesis, matrix mineralization, and accelerates bone regeneration in a sheep model
por: Barker, Alexandra J., et al.
Publicado: (2021)

Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?
por: Noll, J E, et al.
Publicado: (2012)

Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma
por: Friend, Reed, et al.
Publicado: (2017)

Soluble Rank Ligand Produced by Myeloma Cells Causes Generalised Bone Loss in Multiple Myeloma
por: Buckle, Clive Henry, et al.
Publicado: (2012)

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer
por: ZINONOS, IRENE, et al.
Publicado: (2014)

Multiple myeloma presenting in association with gastric phytobezoar
por: Appleton, Elizabeth S., et al.
Publicado: (2017)

Heat shock proteins in multiple myeloma
por: Zhang, Lei, et al.
Publicado: (2014)

Systemic multiple myeloma and colonic abnormalities
por: Pawlak, Katarzyna M., et al.
Publicado: (2023)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models
por: Liapis, Vasilios, et al.
Publicado: (2016)

Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss
por: Deshet-Unger, Naamit, et al.
Publicado: (2016)

Pomalidomide for the Treatment of Multiple Myeloma
por: Clark, Stephen M., et al.
Publicado: (2014)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
por: Liapis, Vasilios, et al.
Publicado: (2017)

Analysis of Updates in Multiple Myeloma Treatment and Management
por: Nieto, Maria Jacqueline, et al.
Publicado: (2023)

Multiple myeloma
por: Collins, Conor D
Publicado: (2004)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

Multiple Myeloma
por: Mandelli, F
Publicado: (1995)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Crawford, A. Muir
Publicado: (1933)

Cannot write session to /tmp/vufind_sessions/sess_v0aa040u3r7cq5em687m0uevbj